Symbiq Infusion Systems Have Cybersecurity Vulnerabilities, FDA Warns
The Symbiq infusion pump may be vulnerable to hacking attempts that could lead to drug overdoses or lack of treatment, federal and company officials warn.
Tag Archives: Symbiq Infusion Pump
-
-
Hospira Medical Device Manufacturing Problems Get FDA Warning
Federal regulators have warned Hospira Inc. over the quality of its medical devices, following an inspection of its Lake Forest, Illinois production facility.
-
Hospira Symbiq Infusion System Recall: Touchscreen Problems on Pumps
A Class one recalled has been issued for one and two channel Symbiq infusion systems sold by Hospira, due to the potential risk that the pump may administer too much…
-
Problems at Hospira Infusion Pump Plant Result in FDA Warning
Hospira has received an FDA warning letter over conditions at an infusion pump factory in Costa Rica, which the agency has deemed to be unacceptable.
-
Symbiq Infusion Pump Recall: System May Not Detect Air in the Line
Problems with Hospira’s Symbiq infusion pumps have resulted in a Class 1 recall this week for two models of infusion sets, as a product defect could cause patients to suffer…
